Primary record
1-(5-Isoquinolinesulfonyl)-1H-hexahydro-1,4-diazepine, Dihydrochloride
- 库存
- 8,908 克
- 纯度
- 99.6 %
- CAS
- 103745-39-7
化合物标识与属性
- CAS
- 103745-39-7
- PubChem CID
- 3547
- SMILES
- C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3
- Canonical SMILES
- O=S(=O)(c1cccc2cnccc12)N1CCCNCC1
名称与同义词
- Fasudil
- Fasudil hydrochloride
- Fasudilum
- 103745-39-7
- Fasudil [INN]
- Eril
- Fasudil?
- ha-1077
- Fasudil HCl
- Fasudilum [INN-Latin]
- 2esm
- 2gni
- zlchem 7
- HA1077
- Fasudil dihydrochloride
- Fasudil (INN)
- AT-877
- Q0CH43PGXS
- Fasudil Impurity 49
- AT 877
- dihydrochloride fasudil
- HA 1077
- UNII-Q0CH43PGXS
- fasudil HCl semihydrate
- 5-(1,4-diazepane-1-sulfonyl)isoquinoline
- Kinome_3390
- Kinome_3391
- Tocris-0541
- 1q8w
- ACMC-20dih9
- 5-(1,4-diazepan-1-ylsulfonyl)isoquinoline
- AC1Q6UWJ
- BiomolKI_000038
- FASUDIL [MI]
- RefChem:597170
- 1-(5-Isoquinolinesulfonyl)homopiperazine
- FASUDIL [WHO-DD]
- BiomolKI2_000046
- C14H17N3O2S
- CHEMBL38380
- D03KKR
- D0V3SO
- Fasudil (HA-1077)
- AC1L1G6K
- AC1Q6VJ2
- SCHEMBL4674
- 1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)-
- AT877
- Fasudil hydrochloride hydrate
- HA-1077 (hydrochloride)
- BSPBio_001111
- DTXSID4048569
- KBioGR_000451
- KBioSS_000451
- CHEBI:43871
- MLS006011953
- NSC-759827
- MFCD00866182
- NGOGFTYYXHNFQH-UHFFFAOYSA-N
- CHEMBL541388
- cid_163751
- GTPL5181
- orb1745275
- ZINC6486
- DTXCID9028201
- SCHEMBL29362990
- SCHEMBL29381868
- BDBM14027
- CTK4A3973
- KBio2_000451
- KBio2_003019
- KBio2_005587
- KBio3_000841
- KBio3_000842
- BRD7868
- C04AX32
- CID3547
- ZK-258594
- ZLA0008
- BCPP000234
- Bio2_000386
- Bio2_000866
- GLXC-21108
- HMS1362G13
- HMS1792G13
- HMS1990G13
- HMS2089F13
- HMS3264M10
- KST-1A0465
- Pharmakon1600-01502366
- (5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE
- ACT06297
- BCP26821
- BRD-7868
- DEA74539
- 3668AH
- AR-1A6371
- C14-H17-N3-O2-S
- EBC-00589
- HY-10341A
- NSC759827
- NSC800098
- Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine
- 5-((1,4-diazepan-1-yl)sulfonyl)isoquinoline
- 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE
- AKOS009604905
- AC-4279
- AN-1326
- AT27735
- BCP9000678
- CCG-100642
- CS-2833
- CS-O-01531
- DB08162
- NE59483
- NSC 759827
- NSC-800098
- SDCCGSBI-0086761.P004
- IDI1_002141
- SMP2_000083
- NCGC00018100-01
- NCGC00018100-02
- NCGC00018100-03
- NCGC00018100-04
- NCGC00018100-05
- NCGC00018100-06
- NCGC00018100-07
- NCGC00024299-02
- NCGC00024299-04
- NCGC00024299-05
- 1-(5-Isoquinolinesulphonyl)homopiperazine
- 1-(5-Isoquinolinylsulfonyl)homopiperazine
- 1-(isoquinoline-5-sulfonyl)homopiperazine
- AJ-08279
- AN-11930
- AS-70114
- BC678601
- LS-60220
- SMR002529471
- AB0109468
- J227.600C
- 2787B
- FT-0602399
- Hexahydro-1-(5-isoquinolylsulfonyl)-1H-1,4-diazepine
- NS00068123
- 5-([1,4]Diazepane-1-sulfonyl)-isoquinoline
- EN300-68842
- 5-[(Hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline
- D07941
- MLS-0003155.0001
- SBI-0086761.0001
- AB00490076-08
- AB00490076_09
- 1-(5-ISOQUINOLINE-SULFONYL)-HOMOPIPERAZINE
- 1-(5-Isoquinolylsulfonyl)-1,4-diazaperhydroepine
- 745F397
- 105628-07-7
- A1202139
- I06-1557
- Q5437132
- BRD-K76617868-001-02-2
- BRD-K76617868-001-03-0
- BRD-K76617868-001-05-5
- BRD-K76617868-003-10-1
- BRD-K76617868-003-11-9
- BRD-K76617868-003-14-3
- BRD-K76617868-300-03-6
- BRD-K76617868-300-04-4
- Fasudil; (5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE
- 5-((HEXAHYDRO-1H-1,4-DIAZEPIN-1-YL)SULFONYL)ISOQUINOLINE
- 5-(hexahydro-1h-1,4-diazepin-1-ylsulfonyl)isoquinoline
- hexahydro-1-(5-isoquinolinesulfonyl)-1h-1,4-diazepine
- N-(5-ISOQUINOLINESULFONYL)-1,4-PERHYDRODIAZEPINE
- Z432085130
- 5-(Hexahydro-1H-1,4-diazepine-1-ylsulfonyl)isoquinoline
- (5-Isoquinolinyl)(hexahydro-1H-1,4-diazepine-1-yl) sulfone
- 1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)- (9CI)
- 1-(5-Isoquinolinesulfonyl)-1H-hexahydro-1,4-diazepine, Dihydrochloride
- 106094-83-1
- 2,3,4,5,6,7-Hexahydro-1-(isoquinolin-5-ylsulfonyl)-1H-1,4-diazepine
- 203911-27-7
- AT 877; AT-877; AT877; HA 1077; HA-1077; HA1077
- ISOQUINOLINE, 5-((HEXAHYDRO-1H-1,4-DIAZEPIN-1-YL)SULFONYL)-
- M77
- FH